Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Trxade Group Inc. (MEDS)

MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Coverage Initiated by Taglich Brothers

Coverage of Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, has been initiated by Taglich Brothers, Inc., a full-service broker dealer focused exclusively on microcap companies. Taglich Brothers offers institutional and retail brokerage services, investment banking … Continue reading

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Appoints Experienced Healthcare Executive as President of Its Emerging Telemedicine Platform

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, recently announced that Ashton Maaraba is joining the Company as President of Bonum Health, Trxade Group’s telemedicine practice. According to the update, Maaraba brings over 20 years of … Continue reading

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

Trxade Group Inc.’s (NASDAQ: MEDS) Pharmaceutical Marketplace Continues Profitable Expansion

Revenues for Q1 2020 up 46% year over year Gross profit of 75% shows viability of business model Close to 12,000 independent pharmacies now using online marketplace Stellar results recently reported by Trxade Group Inc. (NASDAQ: MEDS) are an indication … Continue reading

Posted in Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Plans to Present at the June 2020 Virtual Investor Summit

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the June 2020 Virtual Investor Summit slated to take place June 9-12, 2020. According to the update, Trxade Group management is … Continue reading

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Providing Premium Medical Teleconferences

Trxade Group (NASDAQ: MEDS), through its virtual healthcare subsidiary Bonum Health, provides telehealth services and prescription ordering via teleconferences that are conducted using smart devices. A recent article discussing the company reads, “The service provides subscribers with three premium medical … Continue reading

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Providing COVID-19 Antibody Testing for Commercial Property Firm in Atlanta

Trxade Group (NASDAQ: MEDS) and its wholly owned subsidiary, Integra Pharma Solutions, were recently featured in a CoStar.com article titled ‘Lee & Associates Atlanta to Reopen Office Monday, Offer Coronavirus Antibody Testing’. The article reports that commercial property firm Lee … Continue reading

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

Trxade Group Inc. (NASDAQ: MEDS) Anticipates Successful Year Despite Pandemic, Building on 2019 Growth

Trxade Group Inc.’s technologically nimble health care platform and network help community-based pharmaceuticals meet the challenges of providing medications and medical consultation at lowering costs with efficiency and operational transparency The company’s year-end financial statement for 2019 shows revenues grew … Continue reading

Posted in Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Featured in Dougherty & Company LLC Research Report

Trxade Group Inc. (NASDAQ: MEDS) was featured in a recent equity research report published by Dougherty & Company LLC. The report reads, “We reiterate our Buy rating and $12 Price Target on MEDS following Q1 results that beat expectations. As … Continue reading

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Releases Q1 2020 Financial Results

Trxade Group, Inc. (NASDAQ: MEDS), an integrated telehealth, drug procurement, delivery and online healthcare marketplace, today reported its financial results for the first quarter ended March 31, 2020. Among the highlights, Trxade reported a 46% increase in Q1 2020 revenues … Continue reading

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment

MissionIRNewsBreaks – Trxade Group, Inc.’s (NASDAQ: MEDS) Integral Role in Efforts to Combat COVID-19 Featured in NetworkNewsAudio Podcast

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, was featured in an exclusive NetworkNewsWire (“NNW”) audio podcast, via NNW’s audio press release solutions suite. The podcast contains NNW editorial coverage titled, “Medical Supply Companies Take … Continue reading

Posted in MissionIRNewsBreaks, Trxade Group Inc. (MEDS) | Leave a comment